Auven Therapeutics Management LLLP-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Auven Therapeutics Management LLLP - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013106
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Auven Therapeutics Management LLLP (Auven Therapeutics Management), formerly Celtic Therapeutics Management LLLP is a private equity firm that provides life science investment strategy. The firm invests in therapeutic products or platforms. It has invested in diversified portfolio of biologic and small molecule therapeutic candidates for therapeutic indications. Auven Therapeutics Management’s investment portfolio includes ADC Therapeutics, Spirogen, Kolltan Pharmaceuticals and Sprout Pharmaceuticals. The firm also offers business development stratergy to acquire controlling ownership on therapeutic products. It operates in St. Thomas and Ft. Lauderdale, the US. Auven Therapeutics Management is headquartered in St. Thomas, Virgin islands, the US.

Auven Therapeutics Management LLLP – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Auven Therapeutics Management LLLP, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Auven Therapeutics Management LLLP, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Auven Therapeutics Management LLLP, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Auven Therapeutics Management LLLP, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Auven Therapeutics Management LLLP, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Auven Therapeutics Management LLLP, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
ADC Therapeutics To Raise US$50 Million In Venture Financing 10
Private Equity 12
ADC Therapeutics Raises USD200 Million in Private Placement of Shares 12
Licensing Agreements 13
Auven Therapeutics Enters Into Licensing Agreement With Icahn School Of Medicine At Mount Sinai For Kiacta 13
Celtic Therapeutics Enters Into Licensing Agreement With Resolvyx Pharma For RX-10045 14
Equity Offering 16
ADC Therapeutics Raises USD105 Million in Private Placement of Shares 16
ADC Therapeutics Raises USD80 Million in Private Placement of Shares 17
Acquisition 18
Sun Pharma Acquires Ocular Technologies from Auven Therapeutics 18
MedImmune Acquires Spirogen From Auven Therapeutics For US$440 Million 19
Auven Therapeutics Management LLLP – Key Competitors 21
Auven Therapeutics Management LLLP – Key Employees 22
Auven Therapeutics Management LLLP – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Auven Therapeutics Management LLLP, Pharmaceuticals & Healthcare, Key Facts 2
Auven Therapeutics Management LLLP, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Auven Therapeutics Management LLLP, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Auven Therapeutics Management LLLP, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Auven Therapeutics Management LLLP, Deals By Therapy Area, 2011 to YTD 2017 8
Auven Therapeutics Management LLLP, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
ADC Therapeutics To Raise US$50 Million In Venture Financing 10
ADC Therapeutics Raises USD200 Million in Private Placement of Shares 12
Auven Therapeutics Enters Into Licensing Agreement With Icahn School Of Medicine At Mount Sinai For Kiacta 13
Celtic Therapeutics Enters Into Licensing Agreement With Resolvyx Pharma For RX-10045 14
ADC Therapeutics Raises USD105 Million in Private Placement of Shares 16
ADC Therapeutics Raises USD80 Million in Private Placement of Shares 17
Sun Pharma Acquires Ocular Technologies from Auven Therapeutics 18
MedImmune Acquires Spirogen From Auven Therapeutics For US$440 Million 19
Auven Therapeutics Management LLLP, Key Competitors 21
Auven Therapeutics Management LLLP, Key Employees 22
Auven Therapeutics Management LLLP, Other Locations 23
Auven Therapeutics Management LLLP, Subsidiaries 23

★海外企業調査レポート[Auven Therapeutics Management LLLP-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Microchip Technology Inc (MCHP):企業の財務・戦略的SWOT分析
    Microchip Technology Inc (MCHP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Seek Limited
    Seek Limited - Strategy, SWOT and Corporate Finance Report Summary Seek Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • GSS Infotech Limited (GSS):企業の財務・戦略的SWOT分析
    GSS Infotech Limited (GSS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Ellie Mae Inc (ELLI):企業の財務・戦略的SWOT分析
    Summary Ellie Mae Inc (Ellie Mae) is a technology company that provides cloud-based technology solutions, online network, software and services for the residential mortgage industry. It offers network applications that enable mortgage originators such as mortgage bankers and mortgage brokers, commun …
  • Antitope Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Antitope Ltd (Antitope), a subsidiary of Abzena Plc is a life science company that research and develops technologies for various therapeutic areas. The company’s iTope technology is used to identify peptides; and T Cell Epitope Database is used for screening amino acid sequences from antibo …
  • Cayenne Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Cayenne Medical Inc (Cayenne Medical), a subsidiary of Zimmer Biomet Holdings Inc, is a soft-tissue reconstruction service provider. The company provides knee and shoulder implant products. It offers products such as aperfix femoral, aperfix II tibial, mirror partial knee, cross fix meniscal …
  • JGC Holdings Corp (1963)
    JGC Holdings Corp (1963) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Redbiotec AG-製薬・医療分野:企業M&A・提携分析
    Summary Redbiotec AG (Redbiotec) is a biopharmaceutical company that develops prophylactic vaccines, which target various virus associated diseases. The company produces multi component virus like particles and other protein assemblies through its rePAX coexpression technology. It is developing prod …
  • Autoliv Inc (ALV):企業の財務・戦略的SWOT分析
    Autoliv Inc (ALV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Nanolek:製薬・医療:M&Aディール及び事業提携情報
    Summary Nanolek is a drug development company that offers production of import-substituting and novel pharmaceuticals. The company’s product portfolio includes vaccines, drugs for treatment of leukemias, breast cancer, brain cancer, stomach and ovarian cancer, colorectal cancer, HIV infection and ot …
  • Corby Spirit and Wine Limited:企業の戦略・SWOT・財務情報
    Corby Spirit and Wine Limited - Strategy, SWOT and Corporate Finance Report Summary Corby Spirit and Wine Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • PharmaCyte Biotech Inc (PMCB)-製薬・医療分野:企業M&A・提携分析
    Summary PharmaCyte Biotech Inc (PharmaCyte), formerly Nuvilex Inc is a clinical stage biotechnology company that develops and commercializes treatments for cancer and diabetes. The company’s technology is used for the treatment of advanced and inoperable pancreatic cancer, and diabetes. It develops …
  • The Wharf (Holdings) Limited:企業の戦略・SWOT・財務情報
    The Wharf (Holdings) Limited - Strategy, SWOT and Corporate Finance Report Summary The Wharf (Holdings) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Faron Pharmaceuticals Oy (FARN):製薬・医療:M&Aディール及び事業提携情報
    Summary Faron Pharmaceuticals Oy (Faron) is a clinical stage biopharmaceutical company that conducts clinical stage drug discovery and development. The company's pipeline products focus on cute organ traumas, vascular damage and cancer immunotherapy. It offers Traumakine, that helps to prevent vascu …
  • HCR ManorCare, Inc.:企業の戦略・SWOT・財務情報
    HCR ManorCare, Inc. - Strategy, SWOT and Corporate Finance Report Summary HCR ManorCare, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Foundation Medicine Inc (FMI):製薬・医療:M&Aディール及び事業提携情報
    Summary Foundation Medicine Inc (Foundation Medicine), a subsidiary of F. Hoffmann-La Roche Ltd, is a molecular information products provider. The company provides molecular information and cancer research programs. It offers clinical products such as FoundationOne for solid tumors and FoundationOne …
  • KDDI Corporation (9433):企業の財務・戦略的SWOT分析
    KDDI Corporation (9433) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Dominion Energy Inc.:企業の戦略・SWOT・財務分析
    Dominion Energy Inc. - Strategy, SWOT and Corporate Finance Report Summary Dominion Energy Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Swedbank AB:企業の戦略・SWOT・財務分析
    Swedbank AB - Strategy, SWOT and Corporate Finance Report Summary Swedbank AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Lexmark International Inc:企業の戦略的SWOT分析
    Lexmark International Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆